SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED

(6600)
  Report
Delayed Hong Kong Stock Exchange  -  05/25 04:08:04 am EDT
8.500 HKD   -0.82%
05/20SciClone Pharma Updates Share Buyback Plan
MT
05/19Sciclone Pharmaceuticals Limited Approves Final Dividend for the Year Ended December 31, 2021
CI
04/19China Accepts SciClone Pharma's Clinical Trial Application for Neuroblastoma Immunotherapy
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED
2021Y MABS THERAPEUTICS : mAbs Announces Priorit Review of BLA for DANELZA (naxitamab-gqgk) in..
AQ
2021Y MABS THERAPEUTICS : mAbs Announces NMPA Submission of BLA for DANELZA (naxitamab-gqgk) i..
AQ
2021SCICLONE PHARMACEUTICALS : Form of proxy for the annual general meeting to be held on wedn..
PU
2021SCICLONE PHARMACEUTICALS : Proposed election and re-election of directors and proposed gra..
PU
2021SCICLONE PHARMACEUTICALS : Voluntary Announcement - Official Initiation of the Clinical St..
PU
2021SCICLONE PHARMACEUTICALS : Voluntary Announcement - Formation of the Strategic Cooperation..
PU
2021SCICLONE PHARMACEUTICALS : End of stabilization period, stabilization actions and lapse of..
PU